DekaBank Deutsche Girozentrale’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $230M | Hold |
3,782,490
| – | – | 0.38% | 63 |
|
|
2025
Q4 | $185M | Hold |
3,782,490
| – | – | 0.32% | 67 |
|
|
2025
Q3 | $169M | Hold |
3,782,490
| – | – | 0.28% | 81 |
|
|
2025
Q2 | $176M | Sell |
3,782,490
-111,898
| -3% | -$5.49M | 0.31% | 75 |
|
|
2025
Q1 | $232M | Buy |
3,894,388
+111,898
| +3% | +$6.52M | 0.46% | 48 |
|
|
2024
Q4 | $215M | Hold |
3,782,490
| – | – | 0.4% | 56 |
|
|
2024
Q3 | $194M | Sell |
3,782,490
-454,041
| -11% | -$21.3M | 0.36% | 67 |
|
|
2024
Q2 | $177M | Buy |
4,236,531
+342,143
| +9% | +$15.3M | 0.32% | 72 |
|
|
2024
Q1 | $209M | Sell |
3,894,388
-55,692
| -1% | -$2.84M | 0.39% | 58 |
|
|
2023
Q4 | $203M | Sell |
3,950,080
-56,542
| -1% | -$2.97M | 0.42% | 51 |
|
|
2023
Q3 | $233M | Sell |
4,006,622
-51,769
| -1% | -$3.17M | 0.54% | 32 |
|
|
2023
Q2 | $261M | Buy |
4,058,391
+40,886
| +1% | +$2.74M | 0.59% | 32 |
|
|
2023
Q1 | $273M | Buy |
4,017,505
+289,615
| +8% | +$20.4M | 0.69% | 27 |
|
|
2022
Q4 | $267M | Buy |
3,727,890
+155,558
| +4% | +$11.7M | 0.71% | 24 |
|
|
2022
Q3 | $257M | Buy |
3,572,332
+143,072
| +4% | +$10.4M | 0.76% | 22 |
|
|
2022
Q2 | $264M | Sell |
3,429,260
-5,241
| -0.2% | -$399K | 0.77% | 25 |
|
|
2022
Q1 | $253M | Buy |
3,434,501
+375,680
| +12% | +$25.2M | 0.62% | 30 |
|
|
2021
Q4 | $191M | Sell |
3,058,821
-180,921
| -6% | -$10.6M | 0.46% | 47 |
|
|
2021
Q3 | $196M | Buy |
3,239,742
+94,087
| +3% | +$6.2M | 0.55% | 38 |
|
|
2021
Q2 | $208M | Buy |
3,145,655
+531,821
| +20% | +$34.7M | 0.61% | 34 |
|
|
2021
Q1 | $165M | Buy |
2,613,834
+87,710
| +3% | +$5.46M | 0.55% | 42 |
|
|
2020
Q4 | $156M | Buy |
2,526,124
+26,867
| +1% | +$1.65M | 0.59% | 35 |
|
|
2020
Q3 | $148M | Buy |
2,499,257
+678,409
| +37% | +$40.8M | 0.66% | 33 |
|
|
2020
Q2 | $106M | Buy |
1,820,848
+31,783
| +2% | +$1.9M | 0.67% | 34 |
|
|
2020
Q1 | $98.8M | Buy |
1,789,065
+116,574
| +7% | +$7.13M | 0.76% | 29 |
|
|
2019
Q4 | $108M | Buy |
1,672,491
+1,238,753
| +286% | +$70.9M | 0.66% | 34 |
|
|
2019
Q3 | $22.1M | Sell |
433,738
-24,653
| -5% | -$1.16M | 0.14% | 164 |
|
|
2019
Q2 | $20.9M | Sell |
458,391
-25,329
| -5% | -$1.18M | 0.1% | 218 |
|
|
2019
Q1 | $29.7M | Sell |
483,720
-8,587
| -2% | -$428K | 0.18% | 147 |
|
|
2018
Q4 | $25.1M | Buy |
492,307
+8,587
| +2% | +$461K | 0.17% | 143 |
|
|
2018
Q3 | $29.7M | Sell |
483,720
-34,313
| -7% | -$2.04M | 0.18% | 148 |
|
|
2018
Q2 | $29M | Sell |
518,033
-865,910
| -63% | -$46.8M | 0.19% | 139 |
|
|
2018
Q1 | $87.2M | Buy |
1,383,943
+414,591
| +43% | +$26.7M | 0.6% | 39 |
|
|
2017
Q4 | $56.1M | Hold |
969,352
| – | – | 0.43% | 55 |
|
|
2017
Q3 | $56.1M | Buy |
969,352
+52,709
| +6% | +$3.08M | 0.44% | 55 |
|
|
2017
Q2 | $51.5M | Buy |
916,643
+61,606
| +7% | +$3.35M | 0.41% | 57 |
|
|
2017
Q1 | $47.5M | Buy |
855,037
+53,474
| +7% | +$2.93M | 0.44% | 54 |
|
|
2016
Q4 | $47M | Buy |
801,563
+10,943
| +1% | +$598K | 0.5% | 50 |
|
|
2016
Q3 | $42.6M | Buy |
790,620
+86,550
| +12% | +$5.56M | 0.47% | 53 |
|
|
2016
Q2 | $51.4M | Buy |
704,070
+17,826
| +3% | +$1.26M | 0.58% | 41 |
|
|
2016
Q1 | $43.5M | Buy |
686,244
+52,141
| +8% | +$3.29M | 0.52% | 46 |
|
|
2015
Q4 | $44.1M | Buy |
634,103
+158,663
| +33% | +$10.5M | 0.5% | 48 |
|
|
2015
Q3 | $28.2M | Buy |
475,440
+22,906
| +5% | +$1.45M | 0.34% | 62 |
|
|
2015
Q2 | $30.2M | Sell |
452,534
-71,669
| -14% | -$4.72M | 0.36% | 60 |
|
|
2015
Q1 | $34.3M | Sell |
524,203
-251,189
| -32% | -$15.7M | 0.43% | 53 |
|
|
2014
Q4 | $46.1M | Buy |
775,392
+29,089
| +4% | +$1.64M | 0.58% | 42 |
|
|
2014
Q3 | $38.6M | Buy |
746,303
+89,250
| +14% | +$4.46M | 0.52% | 44 |
|
|
2014
Q2 | $32.4M | Buy |
657,053
+163,816
| +33% | +$8.07M | 0.49% | 44 |
|
|
2014
Q1 | $25.7M | Sell |
493,237
-2,752
| -0.6% | -$146K | 0.41% | 50 |
|
|
2013
Q4 | $26.3M | Buy |
495,989
+70,039
| +16% | +$3.57M | 0.43% | 47 |
|
|
2013
Q3 | $19.5M | Buy |
425,950
+19,201
| +5% | +$843K | 0.34% | 61 |
|
|
2013
Q2 | $18.7M | Buy |
+406,749
| New | +$17.7M | 0.37% | 60 |
|
Other funds holding BMY
VCM
VPM
DekaBank Deutsche Girozentrale's BMY Position: Q1 2026 in Review
DekaBank Deutsche Girozentrale held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 3,782,490 shares worth $230M. The position accounts for 0.38% of the portfolio, ranked #63.
DekaBank Deutsche Girozentrale first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $273M in Q1 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- DekaBank Deutsche Girozentrale held 3,782,490 shares of Bristol-Myers Squibb worth $230M as of Q1 2026.
- DekaBank Deutsche Girozentrale left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.38% of DekaBank Deutsche Girozentrale's portfolio in Q1 2026, its #63 holding.
- DekaBank Deutsche Girozentrale first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- DekaBank Deutsche Girozentrale's Bristol-Myers Squibb position peaked at $273M in Q1 2023.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.